For: | Min HK, Kim SH, Choi JH, Choi K, Kim HR, Lee SH. Impacts of statin and metformin on neuropathy in patients with type 2 diabetes mellitus: Korean Health Insurance data. World J Clin Cases 2021; 9(33): 10198-10207 [PMID: 34904090 DOI: 10.12998/wjcc.v9.i33.10198] |
---|---|
URL: | https://www.wjgnet.com/2307-8960/full/v9/i33/10198.htm |
Number | Citing Articles |
1 |
Jyotsna Needamangalam Balaji, Sreenidhi Prakash, Ashish Joshi, Krishna Mohan Surapaneni. A Scoping Review on the Reported Evidence and Gaps of the Risk of Diabetes in Dyslipidemic Patients under Statin Therapy. Clinics and Practice 2022; 12(4): 565 doi: 10.3390/clinpract12040060
|
2 |
Fatemeh Karami, Hamidreza Jamaati, Natalie Coleman-Fuller, Maryam Shokrian Zeini, A. Wallace Hayes, Mina Gholami, Mahsa Salehirad, Mohammad Darabi, Majid Motaghinejad. Is metformin neuroprotective against diabetes mellitus-induced neurodegeneration? An updated graphical review of molecular basis. Pharmacological Reports 2023; 75(3): 511 doi: 10.1007/s43440-023-00469-1
|
3 |
Pravesh Kanthed, Swapnil Kumar Barasker, C.M. Ravikumar. A Pain Physician’s Perspective on Recent Advances in Painful Diabetic Peripheral Neuropathy Management. Indian Journal of Pain 2024; 38(2): 91 doi: 10.4103/ijpn.ijpn_119_23
|